Compare $GTHP vs $PMI | Chartloom

Compare

$GTHP vs $PMI

Guided Therapeutics Inc · Picard Medical Inc

GTHP

Guided Therapeutics Inc

PMI

Picard Medical Inc

Compare $GTHP vs $PMI

Comparing Guided Therapeutics Inc and Picard Medical Inc

GTHPGuided Therapeutics Inc

PMIPicard Medical Inc

GTHPGuided Therapeutics Inc

Market cap

$19M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

450.8%

YTD performance

-63.0%

52W performance

-20.0%

FCF yield

-7.8%

PMIPicard Medical Inc

Market cap

$974M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-89.6%

52W performance

-97.8%

FCF yield

-1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GTHP

PMI

Detailed metrics comparison

GTHP

Guided Therapeutics Inc

PMI

Picard Medical Inc

Market Cap

GTHP$19M

PMI$974M

Enterprise Value

GTHP$21M

PMI$975M

Price

GTHP$0.20

PMI$9.48

P/E Ratio

GTHPN/A

PMIN/A

P/S Ratio

GTHP29.70x

PMI154.54x

EV/Sales

GTHP32.92x

PMI154.75x

EV/EBITDA

GTHP0.00x

PMI0.00x

P/B Ratio

GTHP33.42x

PMI7.88x

P/FCF Ratio

GTHPN/A

PMIN/A

EV/FCF

GTHP-14.21x

PMI-60.67x

PEG Ratio

GTHPN/A

PMIN/A

Forward P/E (NTM)

GTHPN/A

PMIN/A

Forward P/S (NTM)

GTHPN/A

PMIN/A

Revenue (TTM)

GTHP$650K

PMI$6M

Revenue Growth (YoY)

GTHP450.8%

PMIN/A

Forward Rev Growth

GTHP0.0%

PMI7.3%

Gross Margin (TTM)

GTHP75.8%

PMI18.6%

Operating Margin (TTM)

GTHP0.0%

PMI0.0%

EBITDA Margin (TTM)

GTHP-336.2%

PMI-245.4%

Net Margin (TTM)

GTHP-560.6%

PMI-444.3%

FCF Margin (TTM)

GTHP-231.7%

PMI-255.1%

Net Income (TTM)

GTHP$-4M

PMI$-28M

FCF (TTM)

GTHP$-2M

PMI$-16M

EPS (TTM)

GTHP-$0.04

PMI-$15.08

ROE (TTM)

GTHP-47148.0%

PMI0.0%

ROA (TTM)

GTHP-24393.0%

PMI-19833.0%

ROIC (TTM)

GTHP-37126.0%

PMI0.0%

Cash

GTHP$12K

PMI$38K

Debt

GTHP$2M

PMI$1M

Net Cash/Debt

GTHP$-2M

PMI$-1M

Current Ratio (TTM)

GTHP0.09x

PMI1.02x

Quick Ratio (TTM)

GTHP0.00x

PMI0.09x

Debt/Equity (TTM)

GTHP0.60x

PMI0.78x

Debt/Assets (TTM)

GTHP0.0%

PMI0.0%

Interest Coverage (TTM)

GTHPN/A

PMIN/A

Net Debt/EBITDA (TTM)

GTHP0.00x

PMI0.00x

Beta

GTHP0.69

PMI-2.13

52W Performance

GTHP-20.0%

PMI-97.8%

YTD Performance

GTHP-63.0%

PMI-89.6%

% from 52W High

GTHP-63.0%

PMI-98.6%

% from 52W Low

GTHP66.7%

PMI257.5%

Asset Turnover (TTM)

GTHP0.73x

PMI0.45x

FCF Yield (TTM)

GTHP-7.8%

PMI-1.7%

Earnings Yield (TTM)

GTHP-18.9%

PMI-2.9%

Dividend Yield (TTM)

GTHPN/A

PMIN/A

Rule of 40

GTHP219.2

PMI-255.1

EV/GP/RG

GTHPN/A

PMI114.38

Ticker research

View GTHP research View PMI research

Metric	GTHP Guided Therapeutics Inc	PMI Picard Medical Inc
Market & Valuation
Market Cap	$19M	$974M
Enterprise Value	$21M	$975M
Price	$0.20	$9.48
P/E Ratio	N/A	N/A
P/S Ratio	29.70x	154.54x
EV/Sales	32.92x	154.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	33.42x	7.88x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.21x	-60.67x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$650K	$6M
Revenue Growth (YoY)	450.8%	N/A
Forward Rev Growth	0.0%	7.3%
Profitability
Gross Margin (TTM)	75.8%	18.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-336.2%	-245.4%
Net Margin (TTM)	-560.6%	-444.3%
FCF Margin (TTM)	-231.7%	-255.1%
Net Income (TTM)	$-4M	$-28M
FCF (TTM)	$-2M	$-16M
EPS (TTM)	-$0.04	-$15.08
ROE (TTM)	-47148.0%	0.0%
ROA (TTM)	-24393.0%	-19833.0%
ROIC (TTM)	-37126.0%	0.0%
Financial Health
Cash	$12K	$38K
Debt	$2M	$1M
Net Cash/Debt	$-2M	$-1M
Current Ratio (TTM)	0.09x	1.02x
Quick Ratio (TTM)	0.00x	0.09x
Debt/Equity (TTM)	0.60x	0.78x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.69	-2.13
52W Performance	-20.0%	-97.8%
YTD Performance	-63.0%	-89.6%
% from 52W High	-63.0%	-98.6%
% from 52W Low	66.7%	257.5%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.45x
FCF Yield (TTM)	-7.8%	-1.7%
Earnings Yield (TTM)	-18.9%	-2.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	219.2	-255.1
EV/GP/RG	N/A	114.38
Ticker research	View GTHP research	View PMI research

Valuation

P/S Ratio

GTHP

29.70x

PMI

154.54x

EV/FCF

PMI

-60.67x

GTHP

-14.21x

Growth & revenue

Revenue Growth TTM

GTHP

450.8%

Forward Revenue Growth

PMI

7.3%

GTHP

0.0%

Profitability & performance

Gross Margin

GTHP

75.8%

PMI

18.6%

ROE

PMI

0.0%

GTHP

-47148.0%

FCF Yield %

PMI

-1.7%

GTHP

-7.8%

52-Week Performance

GTHP

-20.0%

PMI

-97.8%

Detailed metrics comparison

GTHP

Guided Therapeutics Inc

PMI

Picard Medical Inc

Market Cap

GTHP$19M

PMI$974M

Enterprise Value

GTHP$21M

PMI$975M

Price

GTHP$0.20

PMI$9.48

P/E Ratio

GTHPN/A

PMIN/A

P/S Ratio

GTHP29.70x

PMI154.54x

EV/Sales

GTHP32.92x

PMI154.75x

EV/EBITDA

GTHP0.00x

PMI0.00x

P/B Ratio

GTHP33.42x

PMI7.88x

P/FCF Ratio

GTHPN/A

PMIN/A

EV/FCF

GTHP-14.21x

PMI-60.67x

PEG Ratio

GTHPN/A

PMIN/A

Forward P/E (NTM)

GTHPN/A

PMIN/A

Forward P/S (NTM)

GTHPN/A

PMIN/A

Revenue (TTM)

GTHP$650K

PMI$6M

Revenue Growth (YoY)

GTHP450.8%

PMIN/A

Forward Rev Growth

GTHP0.0%

PMI7.3%

Gross Margin (TTM)

GTHP75.8%

PMI18.6%

Operating Margin (TTM)

GTHP0.0%

PMI0.0%

EBITDA Margin (TTM)

GTHP-336.2%

PMI-245.4%

Net Margin (TTM)

GTHP-560.6%

PMI-444.3%

FCF Margin (TTM)

GTHP-231.7%

PMI-255.1%

Net Income (TTM)

GTHP$-4M

PMI$-28M

FCF (TTM)

GTHP$-2M

PMI$-16M

EPS (TTM)

GTHP-$0.04

PMI-$15.08

ROE (TTM)

GTHP-47148.0%

PMI0.0%

ROA (TTM)

GTHP-24393.0%

PMI-19833.0%

ROIC (TTM)

GTHP-37126.0%

PMI0.0%

Cash

GTHP$12K

PMI$38K

Debt

GTHP$2M

PMI$1M

Net Cash/Debt

GTHP$-2M

PMI$-1M

Current Ratio (TTM)

GTHP0.09x

PMI1.02x

Quick Ratio (TTM)

GTHP0.00x

PMI0.09x

Debt/Equity (TTM)

GTHP0.60x

PMI0.78x

Debt/Assets (TTM)

GTHP0.0%

PMI0.0%

Interest Coverage (TTM)

GTHPN/A

PMIN/A

Net Debt/EBITDA (TTM)

GTHP0.00x

PMI0.00x

Beta

GTHP0.69

PMI-2.13

52W Performance

GTHP-20.0%

PMI-97.8%

YTD Performance

GTHP-63.0%

PMI-89.6%

% from 52W High

GTHP-63.0%

PMI-98.6%

% from 52W Low

GTHP66.7%

PMI257.5%

Asset Turnover (TTM)

GTHP0.73x

PMI0.45x

FCF Yield (TTM)

GTHP-7.8%

PMI-1.7%

Earnings Yield (TTM)

GTHP-18.9%

PMI-2.9%

Dividend Yield (TTM)

GTHPN/A

PMIN/A

Rule of 40

GTHP219.2

PMI-255.1

EV/GP/RG

GTHPN/A

PMI114.38

Ticker research

View GTHP research View PMI research

Metric	GTHP Guided Therapeutics Inc	PMI Picard Medical Inc
Market & Valuation
Market Cap	$19M	$974M
Enterprise Value	$21M	$975M
Price	$0.20	$9.48
P/E Ratio	N/A	N/A
P/S Ratio	29.70x	154.54x
EV/Sales	32.92x	154.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	33.42x	7.88x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.21x	-60.67x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$650K	$6M
Revenue Growth (YoY)	450.8%	N/A
Forward Rev Growth	0.0%	7.3%
Profitability
Gross Margin (TTM)	75.8%	18.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-336.2%	-245.4%
Net Margin (TTM)	-560.6%	-444.3%
FCF Margin (TTM)	-231.7%	-255.1%
Net Income (TTM)	$-4M	$-28M
FCF (TTM)	$-2M	$-16M
EPS (TTM)	-$0.04	-$15.08
ROE (TTM)	-47148.0%	0.0%
ROA (TTM)	-24393.0%	-19833.0%
ROIC (TTM)	-37126.0%	0.0%
Financial Health
Cash	$12K	$38K
Debt	$2M	$1M
Net Cash/Debt	$-2M	$-1M
Current Ratio (TTM)	0.09x	1.02x
Quick Ratio (TTM)	0.00x	0.09x
Debt/Equity (TTM)	0.60x	0.78x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.69	-2.13
52W Performance	-20.0%	-97.8%
YTD Performance	-63.0%	-89.6%
% from 52W High	-63.0%	-98.6%
% from 52W Low	66.7%	257.5%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.45x
FCF Yield (TTM)	-7.8%	-1.7%
Earnings Yield (TTM)	-18.9%	-2.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	219.2	-255.1
EV/GP/RG	N/A	114.38
Ticker research	View GTHP research	View PMI research